Mutations in GATA2 are rare in juvenile myelomonocytic leukemia

Blood

Volumn 123, Issue 9, 2014, Pages 1426-1427

  Stieglitz, Elliot ^a   Liu, Y Lucy ^b   Emanuel, Peter D ^b   Castleberry, Robert P ^c   Cooper, Todd M ^c   Shannon, Kevin M ^a,d   Loh, Mignon L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 2; GATA2 PROTEIN, HUMAN;

CHILDHOOD LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE MUTATION; GERMLINE MUTATION; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; MISSENSE MUTATION; MONOSOMY 7; MUTATION RATE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SOMATIC MUTATION; CASE REPORT; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MALE; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD;

BASE SEQUENCE; CHILD, PRESCHOOL; GATA2 TRANSCRIPTION FACTOR; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; MALE; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 84899671004     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-11-531079     Document Type: Letter

References (11)

1. Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-2655.
2. Hahn CN, Chong C-E, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-1017.
3. Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929-931.
4. Pasquet M, Bellanné-Chantelot C, Tavitian S, et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 2013;121(5):822-829.
5. Kalra R, Dale D, Freedman M, et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood. 1995;86(12):4579-4586.
6. Calvo KR, Vinh DC, Maric I, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica. 2011;96(8):1221-1225.
7. Bergstraesser E, Hasle H, Rogge T, et al. Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria. Pediatr Blood Cancer. 2007;49(5):629-633. (Pubitemid 350194425)
8. Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol. 2011;152(6):677-687.
9. Castleberry RP, Loh ML, Jayaprakash N, et al. Phase II window study of the farnesyltransferase inhibitor R115777 (Zarnestra®) in untreated juvenile myelomonocytic leukemia (JMML): a Children's Oncology Group study. Blood. 2005;106(11):2587.
10. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073-1081.
11. Liu YL, Castleberry RP, Emanuel PD. PTEN deficiency is a common defect in juvenile myelomonocytic leukemia. Leuk Res. 2009;33(5):671-677.